QA: Viatris Inc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001792044_2023_Viatris_Inc.pdf

Logs

info Minor missing amount for aggregate added to remainder industry.us_generic {'aggregate': 'Revenues', 'missing_ratio': 0.0027500138733883746, 'aggregate_val': 16262700000, 'exp_sum': 16218100000, 'exp_to_value': {'remainder_Revenues': 16218100000}}
info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001792044, Viatris Inc

  xvar xval
0 AssetsCurrent 10,635,400,000
1 IntangibleAssetsNetIncludingGoodwill 33,032,900,000
2 PropertyPlantAndEquipmentNet 3,024,500,000
3 remainder_Assets 3,329,400,000
4 LiabilitiesCurrent 6,746,200,000
5 LiabilitiesNoncurrent 19,771,700,000
6 remainder_Liabilities 2,432,000,000
7 CostOfGoodsAndServicesSold 9,765,700,000
8 SellingGeneralAndAdministrativeExpense 4,179,100,000
9 ResearchAndDevelopmentExpense 662,200,000
10 remainder_Expenses 1,367,800,000
11 remainder_Revenues 16,262,700,000
12 remainder_NetIncome 1,790,700,000
13 remainder_ComprehensiveNetIncome -1,016,900,000
  yvar yval
0 Assets 50,022,200,000
1 Liabilities 28,949,900,000
2 Expenses 15,974,800,000
3 Revenues 16,262,700,000
4 StockholdersEquity 21,072,300,000
5 NetIncome 2,078,600,000
6 ComprehensiveNetIncome 1,570,150,000
7 BaseVar 57,008,600,000
8 EconomicCapitalRatio 0.958

Edgar->Model Mapping

Feature Distribution

Change over Time